Friday, July 10, 2026

pharma · Metastatic Colorectal Cancer · Duchenne Muscular Dystrophy · SMMT

Summit Therapeutics

Summit Therapeutics is a pharma organization headquartered in Miami, USA. It trades on NYSE under ticker SMMT. Primary therapeutic focus areas include Metastatic Colorectal Cancer, Duchenne Muscular Dystrophy, Non-Small

601 Brickell Key Dr, Suite 1000, Miami, Florida 33131, US HQ
2003 Founded
367 Employees
Public company Type
SMMT · NYSE Ticker
Company details
Clinical program

Replens and coconut oil

Phase 1 · other · Genitourinary Abnormality

Replens and coconut oil for Genitourinary Abnormality is a Phase 1 program (other) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).

Internal code GSM

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Summit Therapeutics
Phase
Phase 1
Modality
other
Indication
Genitourinary Abnormality
Status
terminated
Trials
1